Welcome to LookChem.com Sign In|Join Free
  • or
(R)-2-(4-(cyclopropylsulfonyl)phenyl)-N-(pyrazin-2-yl)-3-(tetrahydro-2H-pyran-4-yl)propanaMide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

745051-65-4

Post Buying Request

745051-65-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

745051-65-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 745051-65-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,4,5,0,5 and 1 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 745051-65:
(8*7)+(7*4)+(6*5)+(5*0)+(4*5)+(3*1)+(2*6)+(1*5)=154
154 % 10 = 4
So 745051-65-4 is a valid CAS Registry Number.

745051-65-4Downstream Products

745051-65-4Relevant academic research and scientific papers

Scalable synthesis of a nonracemic α-arylpropionic acid via ketene desymmetrization for a glucokinase activator

Yamagami, Takafumi,Moriyama, Noriaki,Kyuhara, Masahiro,Moroda, Atsushi,Uemura, Takeshi,Matsumae, Hiroaki,Moritani, Yasunori,Inoue, Isao

, p. 437 - 445 (2014/04/17)

Process research and development for a synthesis of the chiral carboxylic acid (R)-2 as a key intermediate of the glucokinase activator (R)-1 is described. The construction of the stereocenter at the α-carbon is a key point for the synthesis of (R)-2. The proposed process utilizes desymmetrization of a ketene in situ generated from the corresponding racemic carboxylic acid Rac-2 with (R)-pantolactone as a chiral auxiliary followed by hydrolysis of the resulting ester. This key step has been successfully scaled up to 20 kg, which demonstrates that this synthetic approach is comparable with a previously reported approach via enantioselective hydrogenation.

Development of an enantioselective hydrogenation based synthesis of a glucokinase activator

Magnus, Nicholas A.,Braden, Timothy M.,Buser, Jonas Y.,Debaillie, Amy C.,Heath, Perry C.,Ley, Christopher P.,Remacle, Jacob R.,Varie, David L.,Wilson, Thomas M.

experimental part, p. 830 - 835 (2012/08/27)

This article describes the development and optimization of chemical reactions and subsequent multikilogram preparation of the glucokinase activator (R)-1 to fund clinical evaluation as a potential therapeutic for type II diabetes. The major process developments presented here are a Wittig olefination isomerization based synthesis of an E-acrylic acid, an optimized enantioselective hydrogenation of the E-acrylic acid, and a challenging final amide coupling.

CRYSTALLINE (R)-2-(4-CYCLOPROPANESULPHONYL-PHENYL)-N-PYRAZIN-2-YL-3-(TETRAHYDROPYRAN-4-YL)-PROPIONAMIDE

-

Page/Page column 4; 5-6, (2009/07/25)

Crystalline R-2-(4-cyclopropanesulfonyl-phenyl)-N-pyrazin-2-yl-3-(tetrahydropyran-4-yl)-propionamide and methods of its preparation and use are disclosed.

ENANTIOSELECTIVE PROCESS

-

Page/Page column 14-15, (2008/06/13)

A process for the production of compounds comprising the enantioselective hydrogenation of 2-substituted acrylic acid derivatives.

TRI(CYCLO) SUBSTITUTED AMIDE COMPOUNDS

-

Page 62, (2008/06/13)

Compounds of Formula (I): or pharmaceutically acceptable salts thereof, are useful in the prophylactic and therapeutic treatment of hyperglycemia and diabetes.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 745051-65-4